Shortwave Life Sciences: Real Assets, Digital & Healthcare Innovation

StockBox

10.8K subscribers

ShareSubscribe

Shortwave Life Sciences: Real Assets, Digital & Healthcare Innovation In this interview StockBox speaks to Exec. Chairman Rolf Gerritsen and Exec. Director Stephen Malloy from Shortwave Life Sciences to discuss the company’s new direction following a business review. 📌 Key highlights: Clinical Trials Moving Ahead – Shortwave is advancing into a human feasibility study for its psychedelic treatment (Psilocybin). Digital Asset Strategy – A new treasury approach will manage digital assets (like Bitcoin) to protect capital, hedge against inflation, and support core clinical operations. Financial Resilience Goals – Importance of institutional-grade partnerships and prudent investing to generate revenue and strengthen the balance sheet. 🔗 Latest Research Talks Video: https://youtu.be/E_6hEJvbD-A?feature=shared 📰 Sign up to our newsletter: https://mailchi.mp/stockboxmedia.com/ 🐦 Follow us on X: https://x.com/StockBoxMedia 🔔 Don’t forget to like, subscribe, and turn on notifications for more updates from StockBox Media! #PSY #StockBox #DigitalAssets #AnorexiaNervosa #ClinicalTrials